-
Company Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
ReShape Lifesciences
Company Profile
Quarter (USD) | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.95 mm | 1.95 mm | 1.95 mm | 1.95 mm | 1.95 mm | 1.95 mm |
Cash burn (monthly) | 353.67 k | 18.42 k | 1.62 mm | 1.86 mm | 653.67 k | 605.50 k |
Cash used (since last report) | 16.36 mm | 851.68 k | 74.75 mm | 86.05 mm | 30.23 mm | 28.00 mm |
Cash remaining | -14.41 mm | 1.09 mm | -72.80 mm | -84.11 mm | -28.28 mm | -26.06 mm |
Runway (months of cash) | -40.7 | 59.4 | -45.0 | -45.2 | -43.3 | -43.0 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|